# Catalent

global GMP capacity (Lonza Visp/US, Catalent, Thermo Fisher Patheon) that lets a sponsor manufacture in-region without owning a plant.

Source: https://en.bioecon.ru/companies/catalent/
Updated: 2026-06-24

- Country: United States

## Verifiable facts

| Fact | Value | Source |
| --- | --- | --- |
| Funding | $1.15 billion in total funding | https://intuitionlabs.ai/articles/top-cdmo-companies-2026-ranked |
| Capacity | Single-use bioreactors up to 2,000 L; 16 GMP suites at Harmans/BWI; Madison site has multiple 2,000 L reactors | https://intuitionlabs.ai/articles/top-cdmo-companies-2026-ranked, https://www.catalent.com/locations/harmans-bwi-united-states, https://www.catalent.com/locations/madison-united-states, https://www.catalent.com/pharma/biologics/manufacturing/cgmp-drug-substance-manufacturing |
| Certification | FDA CGMP, EMA, PMDA, ANVISA, Russian Ministry of Health, ISO 14001, ISO 45001, Ecovadis GOLD, HPRA GMP certified | https://www.catalent.com/locations/harmans-bwi-united-states, https://www.catalent.com/locations/madison-united-states |
| Regulatory approval | Supported multiple regulatory approvals including FDA CBER, EMA, PMDA, ANVISA, and Russian Ministry of Health | https://www.catalent.com/locations/harmans-bwi-united-states, https://www.catalent.com/locations/madison-united-states |
| Production site | More than 40 global sites, including major hubs in Madison, WI and Harmans/BWI, MD | https://www.catalent.com/locations |
| Revenue | $4.38 billion (FY2024) | https://intuitionlabs.ai/articles/top-cdmo-companies-2026-ranked, https://www.sec.gov/Archives/edgar/data/1596783/000159678324000033/R46.htm |

Independent sources: intuitionlabs.ai, sec.gov

## Technologies

- [Bioproduction CDMO/CMO (biologics/ATMP/mRNA)](https://en.bioecon.ru/technology/bioproduction-cdmo-cmo/)
- [Local manufacturing for market access](https://en.bioecon.ru/technology/local-manufacturing-for-market-access/)